Health3 updates
Weight-loss injections as statutory insurance benefit
What happened before and after this story. Background events not previously covered were summarised by AI.
- Background
EU approves Wegovy for chronic weight management in obesity
The EU authorised semaglutide, sold as Wegovy, for long-term weight management, yet German statutory insurers still could not cover it.
- Background
Germany's statutory insurers exclude weight-loss drugs as lifestyle drugs
German law bars statutory health insurers from reimbursing drugs mainly used for weight loss, so patients pay for obesity injections themselves.
Weight-loss jabs on prescription? Barmer boss expects insurers to pay
Germany's public health insurers could soon cover weight-loss injections, says the outgoing head of Barmer. Not everyone agrees, and the price tag is the problem.